Serial 79286968
Live / Registered — Registered (as of 06 Apr 2021)
What this means for you
Registered since 06 Apr 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79286968
- Registration number
- 6311395
- Mark type
- Design / logo
- Filed
- 15 Apr 2020
- Published for opposition
- 19 Jan 2021
- Registered
- 06 Apr 2021
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of disorders of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, for the treatment of dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in the treatment and prevention of oncological related diseases and disorders; pharmaceutical preparations for use in hematology, namely, for the treatment of blood disorders; pharmaceutical preparations for use in the treatment and prevention of ophthalmological diseases and disorders; pharmaceutical preparations for use in the treatment and prevention of gastroenterological diseases and disorders; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, antibacterial substances for medical purposes, antivirals, antibiotics, systemic and topical antifungals
Owner
- NOVARTIS AG, CH
- NOVARTIS AG, CH
- NOVARTIS AG, CH
Prosecution history
- 14 Aug 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 22 Jul 2021 — FINAL DISPOSITION NOTICE SENT TO IB
- 21 Jul 2021 — FINAL DISPOSITION PROCESSED
- 06 Jul 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 06 Apr 2021 — REGISTERED-PRINCIPAL REGISTER
- 24 Jan 2021 — NOTIFICATION PROCESSED BY IB
- 19 Jan 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Jan 2021 — PUBLISHED FOR OPPOSITION
- 30 Dec 2020 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 30 Dec 2020 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 30 Dec 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Dec 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Dec 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Dec 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Dec 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED